ReviewInternational journal of women's health2023
Placenta Accreta Spectrum Diagnosis Challenges and Controversies in Current Obstetrics: A Review.
Review in International journal of women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 30 citations in OpenAlex.
- Evaluating a novel approach to placenta accreta spectrum management: the modified Triple-P technique with cystoinflation (a randomized controlled trial).Scientific reports · 2025Trial
- Placenta Accreta Spectrum: Diagnostic Challenges and Management Strategies.Diagnostics (Basel, Switzerland) · 2026Review
- Placenta Accreta Spectrum in a Patient Without Prior Cesarean Delivery: A Case of Posterior Placenta Previa.Cureus · 2026Article
- Successful conservative management of placenta accreta spectrum in Ethiopia: a case report and literature review.BMC pregnancy and childbirth · 2026Review
- The Prognostic Value and Perioperative Dynamics of the HALP Score in Placenta Accreta Spectrum Surgeries.Journal of clinical medicine · 2025Article
- Prophylactic uterine artery embolization in second-trimester pregnancy termination with placenta previa and accreta spectrum after prior cesarean delivery: a retrospective cohort study.BMC pregnancy and childbirth · 2025Article
- Advances in Prenatal Diagnosis of Placenta Accreta Spectrum.Medicina (Kaunas, Lithuania) · 2025Review
- Efficacy of King's Combined Uterine Suture in Managing Placenta Accreta: A Retrospective Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Dysregulation of decidual NK cell proliferation by impaired decidual cells: a potential contributor to excessive trophoblast invasion in placenta accreta spectrum.Frontiers in cell and developmental biology · 2025Article
- Uterine window and placenta accreta spectrum in a dichorionic, diamniotic twin gestation complicated by postpartum hemorrhage.Radiology case reports · 2024Article
- Placenta praevia.BJA education · 2024Article
- Addressing Diagnosis, Management, and Complication Challenges in Placenta Accreta Spectrum Disorder: A Descriptive Study.Journal of clinical medicine · 2024Article
- Article
- Life-Threatening Obstetrical Emergency: Spontaneous Uterine Rupture Associated with Placenta Percreta in the First Trimester of Pregnancy-Case Report and Literature Review.Reports (MDPI) · 2024Article
- Fostering Excellence in Obstetrical Surgery.Journal of healthcare leadership · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Placenta accreta spectrum (PAS) is the most common obstetric complication in current obstetrics in which the placenta is fully or partially attached to the uterine myometrial layer at delivery. This is commonly due to the deficiency of the uterine interface between the uterine endometrial and myometrial layers leading to abnormal decidualization at the uterine scar area, which permits the abnormally placental anchoring villous and trophoblasts, deeply invade the myometrium. The prevalence of PAS is globally at rising trends every day in modern obstetrics originally due to the high increasing rate of cesarean sections, placenta previa, and assisted reproductive technology (ART). Thus, the early and precise diagnosis of PAS is imperative to prevent maternal intrapartum or postpartum bleeding complications. Objective: The main aim of this review is to debate the current challenges and controversies in the routine diagnosis of PAS diseases in obstetrics. Data Source: We retrospectively reviewed the recent articles on different methods of diagnosing PAS in PubMed, Google Scholar, Web of Science, Medline, Embase, and other website databases. Results: Despite that, the standard ultrasound is a reliable and key tool for the diagnosis of PAS, the lack of ultrasound features does not exclude the diagnosis of PAS. Therefore, clinical assessment of risk factors, MRI tests, serological markers, and placental histopathological tests are also indispensable for the prediction of PAS. Previously, limited studies reached a high sensitivity rate of diagnosis PAS in appropriate cases, while many studies recommended the inclusion of different diagnosis methods to improve the diagnosis accuracy. Conclusion: A multidisciplinary squad with well-experienced obstetricians, radiologists, and histopathologists should be involved in the establishment of the early and conclusive diagnosis of PAS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.